Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies on a new epidermal growth factor-receptor kinase inhibitor, erbstatin, produced by MH435-hF3.

× No keyword cloud information.

24 in total

Review 1. The ERBB network: at last, cancer therapy meets systems biology.

Authors: Yosef Yarden; Gur Pines
Journal: Nat Rev Cancer Date: 2012-07-12 Impact factor: 60.716

Review 2. Treatment for chronic myelogenous leukemia: the long road to imatinib.

Authors: Tony Hunter
Journal: J Clin Invest Date: 2007-08 Impact factor: 14.808

3. Attacking cancer at its foundation.

Authors: Nicholas Lydon
Journal: Nat Med Date: 2009-10 Impact factor: 53.440

Review 4. Streptomyces cloning: useful recombinant DNA systems and a summation of cloned genes.

Authors: P K Tomich
Journal: Antimicrob Agents Chemother Date: 1988-10 Impact factor: 5.191

Review 5. Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents.

Authors: S B Noonberg; C C Benz
Journal: Drugs Date: 2000-04 Impact factor: 9.546

Review 6. Professor Hamao Umezawa opened up a new road for the development of molecularly targeted therapeutic drugs for cancers.

Authors: Masaya Imoto
Journal: J Antibiot (Tokyo) Date: 2017-11-01 Impact factor: 2.649

7. A guanine derivative as a new MEK inhibitor produced by Streptomyces sp. MK63-43F2.

Authors: Masatomi Iijima; Yuji Kubota; Ryuichi Sawa; Yumiko Kubota; Masaki Hatano; Masayuki Igarashi; Manabu Kawada; Isao Momose; Mutsuhiro Takekawa; Masakatsu Shibasaki
Journal: J Antibiot (Tokyo) Date: 2017-09-06 Impact factor: 2.649

Review 8. Antitumor antibiotics discovered and studied at the Institute of Microbial Chemistry.

Authors: T Takeuchi
Journal: J Cancer Res Clin Oncol Date: 1995 Impact factor: 4.553

9. Conversion of epidermal growth factor (EGF) into a stimulatory ligand for A431-cell growth by herbimycin A by decreasing the level of expression of EGF receptor.

Authors: Y Murakami; H Fukazawa; S Mizuno; Y Uehara
Journal: Biochem J Date: 1994-07-01 Impact factor: 3.857

Review 10. Imaging of EGFR and EGFR tyrosine kinase overexpression in tumors by nuclear medicine modalities.

Authors: Eyal Mishani; Galith Abourbeh; Martin Eiblmaier; Carolyn J Anderson
Journal: Curr Pharm Des Date: 2008 Impact factor: 3.116